Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Investigational ErbB-2 tyrosine kinase inhibitors for the treatment of breast cancer

Published:2016-02-29 Issue:4 Volume:25 Page:393-403
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Martinello Rossella,Milani Andrea,Geuna Elena,Zucchini Giorgia,Aversa Caterina,Nuzzo Annamaria,Montemurro Filippo

Funder

Associazione Italiana per la Ricerca sul Cancro

Ministero della Salute

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543784.2016.1153063

Reference75 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. International Variation in Female Breast Cancer Incidence and Mortality Rates

3. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

4. The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy

5. HER2-positive metastatic breast cancer: A changing scenario

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The irreversible ERBB1/2/4 inhibitor neratinib interacts with the BCL-2 inhibitor venetoclax to kill mammary cancer cells;Cancer Biology & Therapy;2018-01-22

2. Methods of selecting combination therapy for colorectal cancer patients: a patent evaluation of US20160025730A1;Expert Opinion on Therapeutic Patents;2017-04-13

3. Isolation of Human Mesenchymal Stem Cells for Studying ErbB Receptor Signaling;Methods in Molecular Biology;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3